Vanberra Signal
Free trial

Mirai Bio

Curated by Signal

Provider of an open end-to-end development platform for genetic medicine development

Health Technologymiraibio.com

Overview

Provider of an open end-to-end development platform for genetic medicine development. It has AI and automation platform that provides biological and biomedical research for DNA, RNA, and protein sequence analysis. It also offer data compilation, analysis algorithms, and scientific article search, enabling researchers to streamline data analysis, gain insights from biological sequences, optimize performance and accelerate drug development.

Key facts

Founded
2021
Headquarters
Cambridge, United States
Stage
Sign up to view
Industry
Health Technology

Business model

5 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Easy Touch

    Online diabetes medical product store

    Health TechnologyHouston, United States

  • 365schedulemanager.com

    Provider of a SaaS-based patient recalling and appointment management system for dentists

    Health TechnologyRye Brook, United States

  • Argus Cognitive

    Provider of software-based medical devices for healthcare

    Health TechnologyHanover, United States

About Mirai Bio

What does Mirai Bio do?

Provider of an open end-to-end development platform for genetic medicine development.

Where is Mirai Bio headquartered?

Mirai Bio is headquartered in Cambridge, United States.

When was Mirai Bio founded?

Mirai Bio was founded in 2021.

Which sector is Mirai Bio in?

Mirai Bio operates in Health Technology.

Who are Mirai Bio's competitors?

Companies similar to Mirai Bio include Easy Touch, 365schedulemanager.com, and Argus Cognitive.